EP Patent

EP0274259A2 — New renin-inhibitory oligopeptides, their preparaton and their use

Assigned to Sankyo Co Ltd · Expires 1988-07-13 · 38y expired

What this patent protects

New renin-inhibitory oligopeptides, their preparaton and their use. Oligopeptides of formula (I): where R 1 -R 5 are various organic groups, and A represents a group of formula -NH-or -(CH 2 ) n -, in which n represents an integer of from 1 to 3, have renin-inhibitory acti…

USPTO Abstract

New renin-inhibitory oligopeptides, their preparaton and their use. Oligopeptides of formula (I): where R 1 -R 5 are various organic groups, and A represents a group of formula -NH-or -(CH 2 ) n -, in which n represents an integer of from 1 to 3, have renin-inhibitory activity and are particularly suitable for oral administration. They may be prepared by condensing their component amino acids or lower oligopeptides using conventional peptide synthesis reactions.

Drugs covered by this patent

Patent Metadata

Patent number
EP0274259A2
Jurisdiction
EP
Classification
Expires
1988-07-13
Drug substance claim
No
Drug product claim
No
Assignee
Sankyo Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.